Allotera Therapeutics (Formerly Wugen) Closes $35 Million Financing to Advance Off-the-Shelf CAR-T Therapies for T-Cell Cancers
Go back to Allotera Therapeutics (Formerly Wugen) Closes $35 Million Financing to Advance Off-the-Shelf CAR-T Therapies for T-Cell Cancers| BANC OF CALIFORNIA (NYSE: BANC) | Delayed: 21.38 +0.05 (0.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.33 | 52 Week High | $23.24 | |||
| Open | $21.02 | 52 Week Low | $10.93 | |||
| Day High | $21.38 | P/E | N/A | |||
| Day Low | $20.86 | EPS | $-0.38 | |||
| Volume | 3,084,784 | |||||
